Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661241 · ClinicalTrials.gov registry record · NA
Mapping the Target for the MRgFUS Treatment of Tremor
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04661241 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 6 participants.
The verdict
NCT04661241, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.
Interventions
- OTHER Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches
- OTHER Routine clinical MRI protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661241
The ClinicalTrials.gov registry entry for NCT04661241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches is the first listed.
NCT04661241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04661241 about?
NCT04661241 is a clinical study titled "Mapping the Target for the MRgFUS Treatment of Tremor". The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.
What is the current status of trial NCT04661241?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-09-10. Estimated completion is 2022-06-15.
What interventions are being tested in trial NCT04661241?
The interventions under investigation include: Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches (OTHER), Routine clinical MRI protocol (OTHER).
Who is sponsoring clinical trial NCT04661241?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.